Table 1.
PAWG-recommended weight-band dosing for DRV single compound and DRVr co-formulation to be used twice daily as part of second- or third-line regimens*
| Number of tablets/mL by weight-band morning and evening | |||||||
|---|---|---|---|---|---|---|---|
|
|
|||||||
| Drugs | Strength of paediatric tab (mg) | 3–5.9 kg | 6–9.9 kg | 10–13.9 kg | 14–19.9 kg | 20–24.9 kg | 25–29.9 kg |
| DRVa | 100 mg/mL | NR | NR | 2.5 (250 mg) | 3.5 (350 mg) | – | – |
| DRVa | 75 mg tablets | NR | NR | 3 (225 mg) | 5 (375 mg) | 5 (375 mg) | 5 (375 mg) |
| DRV/r | 120/20* | NR | NR | 2 (240 mg) | 3 (360 mg) | 3 (360 mg) | 4 (480 mg) |
a
DRV single-strength dosing must be used with the appropriate dosing of RTV.